Status:
COMPLETED
EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients
Lead Sponsor:
Klinik für Kinder- und Jugendmedizin
Conditions:
Epstein-Barr Virus Infections
Eligibility:
All Genders
Brief Summary
Question: In which stage of an EBV-infection is a selective reduction of immunosuppressive medication reasonable to minimize the risk for PTLD, without putting the transplant recipient at risk of acu...
Detailed Description
PTLD represents a heterogeneous group of abnormal lymphoid proliferations, generally of B-cells, that occur in the setting of ineffective T-cell function because of pharmacological immunosuppression. ...
Eligibility Criteria
Inclusion
- male and female pediatric and adult renal transplant recipients with written informed consent
Exclusion
- psychological illness which does not allow patient to understand the study and participate following his own free will
- no written informed consent
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00963248
Start Date
July 1 2003
End Date
August 1 2010
Last Update
April 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Britta Hoecker
Heidelberg, Germany, 69120